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RESUMO.- [Avaliação do antígeno recombinante p24 para
a detecção de anticorpos específicos do Vírus da
Imunodeficiência Felina.] O vírus da imunodeficiência felina
tem distribuição mundial e é considerado um patógeno signi-
ficativo. No Brasil, a prática diagnóstica é baseada principal-
mente em teste rápidos, importados e de custo elevado, dis-
poníveis comercialmente.  Devido ao seu custo proibitivo em
nosso país, o diagnóstico da infecção pelo FIV é raramente
realizado. Ademais, os lentivírus se multiplicam lenta e po-
bremente em cultura de células, o que torna a produção de
antígeno por meios clássicos e o estabelecimento do
imunodiagnóstico impraticável. Com o objetivo de lidar com
esta questão, técnicas de DNA recombinante foram utiliza-
das para produção de um antígeno do capsídeo viral, a prote-
ína p24.  A avaliação da reatividade realizada por Western
blot indicou que este antígeno recombinante pode ser útil para
o imunodiagnóstico de infecções pelo FIV.
TERMOS DE INDEXAÇÃO: FIV, vírus da imunodeficiência
felina, gatos.
INTRODUCTION
Feline Immunodeficiency Virus (FIV) is a lentivirus that cau-
ses a chronic and progressive immunodeficiency and is
considered one of the main pathogens of domestic felines.
Infected cats show a progressive depletion of CD4+ T-
lymphocytes and immunological deficits which, after a long
asymptomatic period, may lead to severe opportunistic
infections followed by death, characterizing the clinical phase
known as Feline Acquired Immunodeficiency Syndrome
(FAIDS). Due to the similarity to HIV, FIV-infected cats have
been used as experimental models for HIV/AIDS (De
Rozieres et al. 2004).
FIV is structured like other lentiviruses. Virions measure
80-100 nm in diameter and consist of an envelope, a
nucleocapsid, a nucleoid and a matrix protein. Surface
projections of 8 nm length are densely dispersed, small,
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inconspicuous spikes that cover evenly the surface. Each
virion also contains two copies of the positive-stranded,
polyadenylated RNA genome of about 9400 base pairs.
The viral genome is divided in three genes, gag, pol and
env that codify internal structural proteins, reverse
transcriptase and other enzymes and envelope proteins,
respectively. There are other several accessory genes
(Olmsted et al. 1989, Bendinelli et al. 1995).
Naturally, the control of the disease is linked to the
diagnosis of FIV infections, which relies mainly on the
detection of specific antibodies which are considered
indicators of the persistent infection. Most available FIV
diagnostic tests detect serum, plasma, or whole blood
antibodies to FIV. The American Association of Feline
Practitioners recommends the use of antibody assays to
determine the FIV status of all cats, regardless of age or
health status, even with an increase of the vaccination
practice (Levy et al. 2008).
An ELISA of immobilized labeled antigens that bind to
antibodies is the only available FIV test for commercial or
in-practice laboratories in North America and other countries,
including Brazil. These tests come in kit format for in-
practice use, or in a microwell format for laboratory use.
This ELISA is based on detection of antibodies against the
viral nucleocapsid protein p24 and a positive or negative
result depends on a chromogenic reaction relative to a
positive control (O’Connor et al. 1989, Mermer et al. 1992).
The p24 is the major nucleocapsid protein encoded by the
gag gene. Antibody detection against p24 is commonly used
in FIV infection diagnosis due to its high conservation and
antigenic characteristics (Calzolari et al. 1995, Mermer et
al. 1992, Reid et al. 1992).  Western blot is also available
and is often recommended for confirmatory testing of ELISA
positive samples (Barr 1996, Levy et al. 2008).
Nevertheless, routine and research diagnosis for FIV
infections still remain problematic in some parts of the world
such as Brazil. Despite its large worldwide diffusion and
application, the ELISA based rapid tests usage still depends
on imported kits with highly restrictive costs in Brazil.
Moreover, any immunodiagnostic technique depends on
the antigen source and in the case of lentiviruses on viral
cultivation in cell cultures, which is expensive and time-
consuming. Perhaps, these factors are the greatest
obstacles for the availability of FIV diagnosis in our country
The production of viral proteins by recombinant bacte-
ria or other biological systems has been used for different
purposes as an alternative technology to classic methods
of protein purification from cultivated virus. Such alternatives
are of special interest for viruses that are hardly grown in
cell cultures such as lentiviruses. Basically, the desired
coding region is ligated in a DNA vehicle as a bacterial
plasmid and this construct is inserted in a appropriate
biological system to express the recombinant protein, like
bacteria. Cultures of recombinant bacteria represent a
practical source of the heterologous protein.
With the aim to contribute to FIV diagnosis in Brazil, a
recombinant antigen produced by Escherichia coli was
developed and its reactivity against sera samples of
naturally infected and non-infected cats was evaluated by
Western blot (WB), the gold standard test for the diagnosis
of FIV and several virus infections.
MATERIALS AND METHODS
Cloning procedures. A DNA sample obtained from the
peripheral blood mononuclear cells (PBMC) of a naturally FIV-
infected cat was used successfully in order to amplify the p24
coding region by the PCR. The primer’s design was based on
the complete FIV B genomic sequence (Genbank/nucleotide
database accession number M59418) and the characteristics
of the chosen expression vector (pET100/D-TOPO®, Invitrogen)
(5’-CACCATGCCTATTCAAACAGTAAATGGAG-3’, forward and
5’-CAAGAGTTGCATTTTATATCCTGGTGAGCC-3’, reverse).
The obtained amplicon was inserted in the plasmid expression
vector following the manufacturer‘s recommendations. The
correct insertion of the p24 coding region in the recombinant
plasmid was confirmed by nucleotide sequencing.
Recombinant protein production. After the transformation
of the recombinant plasmid by electroporation, the recombi-
nant protein p24 (r-p24) was over expressed in the selected
recombinant bacterial clone induced with 1M IPTG (isopropyl-
D-thiogalactopyranoside) in a shaker incubator at 37oC for 4
hours. The purification based on the poly-histidine tail added to
the recombinant protein was performed by immobilized metal
affinity in nickel-charged resin (IMAC). The purified r-p24 was
characterized by polyacrylamide gel electrophoresis (SDS-
PAGE) that showed a protein of approximately 30 kDa and by
WB with anti-histidine monoclonal antibodies.
Western blot assay. WB assays were conducted on a
nitrocellulose membrane with about 1.8μg r-p24 protein/cm.
For the evaluation of the r-p24 reactivity, 30 seronegative and
Fig.1. Western blot performed with the r-p24. The strips contain
500ng of the purified r-p24 (30 kDa) incubated with a
negative (1) and positive (2) control serum diluted at 1:50.
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30 seropositive cat serum samples, tested previously by PCR
for gag gene and ELISA were used. Basically, this assay was
carried out using cat serum samples diluted 1/50 in milk TBS-T
(4% non-fat milk in Tris-tween buffered saline) and horseradish
peroxidase-conjugated anti-cat rabbit immunoglobulin (Fig.1).
Statistical analysis. The chi-square test was chosen to
evaluate the agreement between the WB versus PCR and ELISA
results. The number of control sera samples, 30 positive e 30
negative, was adopted based on chi-square analysis needs.
RESULTS
The WB assays indicated an agreement of 100% with the
previously performed PCR and ELISA tests, what means
that all the 30 positive sera reacted with the r-p24 and
that unspecific reactions were not observed in any of the
30 negative sera samples.  This result made the chi-square
analysis dispensable.
DISCUSSION
Pedersen et al. (1987) described the isolation of a T-
lymphotropic virus with the characteristics of a lentivirus
from pet cats in Davis, California. Since then, it was evident
that the virus is of substantial veterinary importance. In
addition, the FIV infection exposes felines to opportunistic
and pathogenic infectious agents, including some zoonotic
ones such as toxoplasmas, bartonellas and even possibly,
avian pandemic influenza virus (H5N1) (Lappin et al. 1992,
Ueno et al. 1996).
FIV infections in cats can be diagnosed by different
techniques: based on virus isolation from a peripheral blood
lymphocyte culture, demonstration of specific antibodies
or molecularly, using the PCR. Virus isolation is technically
demanding, expensive, and takes several weeks, hence it
hardly can be considered for routine diagnose purposes.
PCR is frequently used to detect, quantify, and assess
genetic variations of infectious agents but FIV is difficult
to detect by PCR, since gene sequences differ by as much
as 20% among field isolates (Bachmann et al. 1997).
Moreover, the amount of virus in blood is low during the
clinically silent phase of infection, when most testing is
performed (Pedersen et al. 1989). These aspects bring the
use of nested PCR approaches, which increase possibilities
for false positive results.
FIV antibodies can be detected by the immunofluores-
cence assay using FIV-infected lymphocytes, ELISA,
Western blot and radioimmunoprecipitation assays.
Anyway, with the exception of PCR, these techniques
depend on the antigen production. Considering the difficulties
in obtaining lentivirus antigens from cell cultures, recombi-
nant DNA technology is a simple, economic and available
system to produce viral antigens.
FIV diagnostic techniques can be mostly found in the
ELISA format, microwell plates and lateral flow systems
(rapid tests) that are commercially available. Rapid tests
are the most frequently used at veterinary clinics and ani-
mal shelters around the world, due to its simplicity and low
time consumption (Crawford & Levy 2007). However, even
considering these advantages, the actual cost of these tests
showed to be impeditive in countries where it is imported.
The microwell ELISA used in veterinary laboratories has
been described as having high sensitivity and specificity
(Barr et al. 1991). False negative results are rare and mostly
due to acute infection prior to the generation of specific
antibodies. False positive results have been attributed to
poor technique and nonspecific reactivity against tissue
culture components following vaccination. Based on these
test characteristics, it was recommended that a positive
in-practice ELISA in a healthy cat should be confirmed with
a Western blot (Barr 1996).
There is a great veterinary interest in a large scale FIV
epidemiologic survey in Brazil but the high costs of the
rapid test and the difficulty to obtain the viral antigen by
classical ways to establish immunodiagnostic techniques
may explain the availability of just a few epidemiologic
studies found in Brazil and its low numbers of surveyed
animals (Teixeira et al. 2007, Caxito 2003, Hagiwara et al.
1987, Laral et al. 2008, Souza et al. 2002). The obtained
recombinant bacteria represent a good source for viral
antigen production in order to establish alternative diagnosis
methods.
CONCLUSION
The results of the WB assays show that r-p24 can be
suitable for the detection of FIV antibodies. The simple
and inexpensive production of the r-p24 favors the esta-
blishment of FIV immunodiagnostic techniques for
epidemiologic and clinical applications of this important
animal disease.
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